Bayesian modelling for COVID-19 seroprevalence studies
Por um escritor misterioso
Descrição
Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys
Screening of COVID-19 cases through a Bayesian network symptoms model and psychophysical olfactory test - ScienceDirect
Bayesian modelling for COVID-19 seroprevalence studies
Data-driven modeling of covid-21 - living matter lab
Bayesian inference across multiple models suggests a strong increase in lethality of COVID-19 in late 2020 in the UK
A note on COVID-19 seroprevalence studies: a meta-analysis using hierarchical modelling
Inferring the COVID-19 infection fatality rate in the community-dwelling population: a simple Bayesian evidence synthesis of seroprevalence study data and imprecise mortality data, Epidemiology & Infection
Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys
Estimating seroprevalence of SARS-CoV-2 in Ohio: A Bayesian multilevel poststratification approach with multiple diagnostic tests
Seroprevalence, spatial distribution, and social determinants of SARS-CoV-2 in three urban centers of Chile, BMC Infectious Diseases
Using outbreak data to estimate the dynamic COVID-19 landscape in Eastern Africa, BMC Infectious Diseases
Estimation of age-stratified contact rates during the COVID-19 pandemic using a novel inference algorithm
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard
Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance
de
por adulto (o preço varia de acordo com o tamanho do grupo)
